Suppr超能文献

从 中分离得到的两种新型类异戊二烯黄酮,具有抗氧化和细胞毒性活性。

Two New Isoprenoid Flavonoids from with Antioxidant and Cytotoxic Activities.

机构信息

Guizhou Provincial Key Laboratory of Pharmaceutics, Guiyang 550025, China.

School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550025, China.

出版信息

Molecules. 2021 Nov 29;26(23):7228. doi: 10.3390/molecules26237228.

Abstract

is a regularly used traditional Chinese medicine. In an attempt to discover adequate active agents, the isoprenoid flavonoids from were further investigated. In this work, two new compounds (-, kurarinol A-B) together with 26 known ones (-) were isolated and elucidated on the basis of extensive NMR, UV and MS analyses. Furthermore, the antioxidant activity of all constituents was assessed through ABTS, PTIO and DPPH methodologies and also were evaluated for cytotoxic activity by three tumor cell lines (HepG2, A549 and MCF7) and one human normal cell line (LO2 cells). As a result, a multitude of components revealed significant inhibitory activity. In particular, compound - (kurarinol A-B), two new flavanonols derivatives, exhibited the most potent ABTS inhibitory activity with IC of 1.21 µg/mL and 1.81 µg/mL, respectively. Meanwhile, the new compound demonstrated remarkable cytotoxicity against three cancer cells lines with IC values ranging from 7.50-10.55 μM but showed little effect on the normal cell. The two new isoprenoid flavonoids could be promising antioxidant and anti-tumor nature agents.

摘要

是一种常用的中药。为了发现有效的活性成分,我们对 中的异戊烯基类黄酮进行了进一步研究。在这项工作中,基于广泛的 NMR、UV 和 MS 分析,我们从 中分离并鉴定了两种新化合物(-,苦参素 A-B)和 26 种已知化合物(-)。此外,通过 ABTS、PTIO 和 DPPH 方法评估了所有成分的抗氧化活性,并通过三种肿瘤细胞系(HepG2、A549 和 MCF7)和一种人正常细胞系(LO2 细胞)评估了它们的细胞毒性。结果表明,许多成分具有显著的抑制活性。特别是化合物 -(苦参素 A-B),两种新的类黄酮衍生物,对 ABTS 的抑制活性最强,IC 值分别为 1.21 µg/mL 和 1.81 µg/mL。同时,新化合物 对三种癌细胞系表现出显著的细胞毒性,IC 值范围为 7.50-10.55 μM,但对正常细胞影响较小。这两种新的异戊烯基类黄酮可能是有前途的抗氧化和抗肿瘤天然药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310e/8658773/5839279f6c1a/molecules-26-07228-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验